Riverview Trust Company’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-174
Closed -$60.1K 369
2025
Q1
$60.1K Sell
174
-6
-3% -$1.93K 0.06% 197
2024
Q4
$54K Buy
180
+2
+1% +$699 0.05% 214
2024
Q3
$72.3K Buy
178
+4
+2% +$1.46K 0.06% 196
2024
Q2
$55.9K Hold
174
0.05% 208
2024
Q1
$58K Buy
+174
New +$53.2K 0.04% 223
2023
Q4
Sell
-174
Closed -$42.8K 318
2023
Q3
$42.8K Hold
174
0.04% 256
2023
Q2
$52.8K Hold
174
0.05% 201
2023
Q1
$45.9K Hold
174
0.04% 220
2022
Q4
$42K Buy
+174
New +$39K 0.04% 235
2022
Q3
Sell
-84
Closed -$14K 786
2022
Q2
$14K Sell
84
-96
-53% -$20.6K 0.01% 516
2022
Q1
$45K Buy
+180
New +$45.2K 0.03% 231

Other funds holding HCA

Riverview Trust Company's HCA Position: Q2 2025 in Review

Riverview Trust Company sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 174 shares — an estimated $60.1K sold.

Riverview Trust Company first reported a position in HCA in Q1 2022 and held it in 11 quarters. The position peaked at $72.3K in Q3 2024. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Riverview Trust Company reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 174 HCA Healthcare shares in Q2 2025, an estimated $60.1K.
  • Riverview Trust Company first reported a position in HCA Healthcare in Q1 2022 and held it in 11 quarters.
  • Riverview Trust Company's HCA Healthcare position peaked at $72.3K in Q3 2024.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.